arrow
F

Federica Pinna

university of cagliari
H指数:36
被引数:4,092

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Italian Version of the Lesbian, Gay, Bisexual and Transgender Development of Clinical Skills Scale (LGBT-DOCSS): Validation Among Mental Health Professionals

意大利语版男同性恋、女同性恋、双性恋和跨性别者临床技能发展量表(LGBT-DOCSS):在心理健康专业人士中的验证

2026-09-280
PRE
Digital mental health in Italy: findings from the multicentric DIGIT-PSY study

意大利数字心理健康:多中心DIGIT-PSY研究的结果

2025-08-290
OA
Identifying molecular signatures of post-traumatic stress disorder vulnerability and progression in a longitudinal study: a study protocol

识别创伤后应激障碍易感性和进展的分子特征:一项纵向研究方案

2025-08-050
OA
Corrigendum to “A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder” [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292]

勘误:关于“基于CYP2D6和CYP2C19分型的药代遗传学检测在重度抑郁症患者抗抑郁治疗中的效用:一项自然主义回顾性评估”[神经精神药理学与生物精神病学进展(2025)111292]

2025-07-210
PREAI
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort

与精神药理学基因相关的重度抑郁症治疗结局:撒丁岛队列研究的结果

2025-04-230
PRE
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression

重复经颅磁刺激对临床和认知结局以及脑源性神经营养因子水平的影响,在难治性抑郁症中的应用

2025-04-080
OA
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder
2025-03-010
OAAI
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis

精神分裂症的应对,复原力和自尊的遗传决定因素表明社会因素和海马神经发生的主要作用

2024-10-010
PRE
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People With Schizophrenia and Schizoaffective Disorder?

长效注射抗精神病药是否会影响精神分裂症和分裂情感障碍患者的血清脑源性神经营养因子水平?

2024-08-120
OA
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data
2024-04-012
OAAI
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
2024-01-160
OAAI
The interplay between mentalization, personality traits and burnout in psychiatry training: Results from a large multicenter controlled study

精神病学培训中的心理化,人格特质和倦怠之间的相互作用: 一项大型多中心对照研究的结果

2024-01-033
OA
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study
2023-12-013
OAAI
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
2023-11-2313
OAAI
Family functioning and personal growth in Italian caregivers living with a family member affected by schizophrenia: Results of an add-on study of the Italian network for research on psychoses
2023-01-134
OAAI
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder
2022-11-174
OAAI